(Q46132298)

19 December 2017

title

Increased systemic exposure of fimasartan, an angiotensin II receptor antagonist, by ketoconazole and rifampicin (English)

1 reference

19 December 2017

author

Min Goo Lee

7

1 reference

19 December 2017

Joo-Youn Cho

6

object named as

Joo-Youn Cho

1 reference

19 December 2017

author name string

Jung Won Kim

1

1 reference

19 December 2017

SoJeong Yi

2

1 reference

19 December 2017

Tae-Eun Kim

3

1 reference

19 December 2017

Kyoung Soo Lim

4

1 reference

19 December 2017

Seo Hyun Yoon

5

1 reference

19 December 2017

Im-Sook Song

8

1 reference

19 December 2017

Sang-Goo Shin

9

1 reference

19 December 2017

In-Jin Jang

10

1 reference

19 December 2017

Kyung-Sang Yu

11

1 reference

19 December 2017

publication date

24 January 2013

1 reference

19 December 2017

The Journal of Clinical Pharmacology

published in

1 reference

19 December 2017

volume

53

1 reference

19 December 2017

issue

1

1 reference

19 December 2017

page(s)

75-81

1 reference

19 December 2017

The need for multiple doses of 400 mg ketoconazole as a precipitant inhibitor of a CYP3A substrate in an in vivo drug-drug interaction study.

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0091270011433328

Inhibitory effects of ketoconazole and rifampin on OAT1 and OATP1B1 transport activities: considerations on drug-drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270011433328

Elucidating the effect of final-day dosing of rifampin in induction studies on hepatic drug disposition and metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270011433328

Inhibitory and inductive effects of rifampin on the pharmacokinetics of bosentan in healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270011433328

Rifampicin seems to act as both an inducer and an inhibitor of the metabolism of repaglinide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270011433328

Dual effects of rifampin on the pharmacokinetics of atrasentan

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270011433328

Effect of ketoconazole on the pharmacokinetics of rosiglitazone in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270011433328

Effect of silymarin supplement on the pharmacokinetics of rosuvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270011433328

Rifamycin SV and rifampicin exhibit differential inhibition of the hepatic rat organic anion transporting polypeptides, Oatp1 and Oatp2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270011433328

Ketoconazole and rifampin significantly affect the pharmacokinetics, but not the safety or QTc interval, of casopitant, a neurokinin-1 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270011433328

Differentiation of intestinal and hepatic cytochrome P450 3A activity with use of midazolam as an in vivo probe: effect of ketoconazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270011433328

The effect of ketoconazole on the pharmacokinetics of a selective alpha 1A-adrenoceptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270011433328

Human organic anion transporting polypeptide-C (SLC21A6) is a major determinant of rifampin-mediated pregnane X receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270011433328

Interactions of rifamycin SV and rifampicin with organic anion uptake systems of human liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270011433328

Influence of drugs interacting with CYP3A4 on the pharmacokinetics, pharmacodynamics, and safety of the prandial glucose regulator repaglinide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270011433328

Rifampin decreases the plasma concentrations and effects of repaglinide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270011433328

The Effect of the Newly Developed Angiotensin Receptor II Antagonist Fimasartan on the Pharmacokinetics of Atorvastatin in Relation to OATP1B1 in Healthy Male Volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270011433328

Effect of SLCO1B1 polymorphism on induction of CYP3A4 by rifampicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270011433328

21 January 2018

Identifiers

DOI

10.1177/0091270011433328

1 reference

19 December 2017

1 reference

19 December 2017